These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19723672)

  • 21. Phenytoin hypersensitivity syndrome with positive patch test. A possible cross-reactivity with amitriptyline.
    Galindo Bonilla PA; Romero Aguilera G; Feo Brito F; Gómez Torrijos E; García Rodríguez R; Cortina de la Calle P; Encinas Barrios C
    J Investig Allergol Clin Immunol; 1998; 8(3):186-90. PubMed ID: 9684195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
    Petkov T; Pehlivanov G; Grozdev I; Kavaklieva S; Tsankov N
    Eur J Dermatol; 2007; 17(5):422-7. PubMed ID: 17673387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenytoin and carbamazepine cross reactivity: report of a case and review of literature.
    Misra UK; Kalita J; Rathore C
    Postgrad Med J; 2003 Dec; 79(938):703-4. PubMed ID: 14707249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.
    Yun SJ; Lee JB; Kim EJ; Quan G; Kim SJ; Won YH; Lee SC
    Acta Derm Venereol; 2006; 86(3):241-4. PubMed ID: 16710584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    D'Orazio JL
    Clin Toxicol (Phila); 2008 Dec; 46(10):1093-4. PubMed ID: 18821094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticonvulsant hypersensitivity syndrome to carbamazepine].
    Gall H; Merk H; Scherb W; Sterry W
    Hautarzt; 1994 Jul; 45(7):494-8. PubMed ID: 7928347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mononucleosis-like illness as a manifestation of carbamazepine-induced anticonvulsant hypersensitivity syndrome.
    Maquiera E; Yañez S; Fernández L; Rodríguez F; Picáns I; Sánchez I; Jeréz J
    Allergol Immunopathol (Madr); 1996; 24(2):87-8. PubMed ID: 8933895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine-induced pseudolymphoma with CD-30 positive cells.
    Nathan DL; Belsito DV
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):806-9. PubMed ID: 9591791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine hypersensitivity syndrome.
    Balasubramanian S; Shobhana S; Padmasani LN; Natarajan M; Rao R
    Indian Pediatr; 1999 Jan; 36(1):98-9. PubMed ID: 10709136
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.
    Karande S; Gogtay NJ; Kanchan S; Kshirsagar NA
    Indian J Med Sci; 2006 Feb; 60(2):59-63. PubMed ID: 16505575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations.
    Alldredge BK; Knutsen AP; Ferriero D
    Pediatr Neurol; 1994 Mar; 10(2):169-71. PubMed ID: 8024670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review.
    Gaeta F; Alonzi C; Valluzzi RL; Viola M; Elia M; Romano A
    Curr Pharm Des; 2008; 14(27):2874-82. PubMed ID: 18991705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
    Pereira de Silva N; Piquioni P; Kochen S; Saidon P
    Eur J Clin Pharmacol; 2011 May; 67(5):463-70. PubMed ID: 21359537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity.
    Houwerzijl J; De Gast GC; Nater JP; Esselink MT; Nieweg HO
    Clin Exp Immunol; 1977 Aug; 29(2):272-7. PubMed ID: 908175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anticonvulsant hypersensitivity syndrome].
    Papp Z; Török L
    Orv Hetil; 2004 Aug; 145(32):1665-8. PubMed ID: 15384865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS).
    Newell BD; Moinfar M; Mancini AJ; Nopper AJ
    Pediatr Dermatol; 2009; 26(5):536-46. PubMed ID: 19840307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes].
    Veyrac G; Marcade G; Chiffoleau A; Bourin M; Jolliet P
    Therapie; 2002; 57(3):289-96. PubMed ID: 12422544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome].
    Taillia H; Alla P; Fournier B; Bounolleau P; Ouologem M; Ricard D; Sallansonnet-Froment M; de Greslan T; Renard JL
    Rev Neurol (Paris); 2009 Oct; 165(10):821-7. PubMed ID: 19362726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypersensitivity reactions to antiepileptic drugs in children.
    Atanasković-Marković M; Janković J; Tmušić V; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Škorić D
    Pediatr Allergy Immunol; 2019 Aug; 30(5):547-552. PubMed ID: 30951222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of type IV hypersensitivity to topiramate and carbamazepine.
    Schiavino D; Nucera E; Buonomo A; Musumeci S; Pollastrini E; Roncallo C; Lombardo C; Alonzi C; Pecora V; Corradini C; De Pasquale T; Patriarca G
    Contact Dermatitis; 2005 Mar; 52(3):161-2. PubMed ID: 15811034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.